New mRNA Cancer “Vaccine” Targets Aggressive Brain Tumors
A new mRNA cancer biological labeled a “vaccine” is showing promise in treating an aggressive type of brain cancer called glioblastoma. The novel cancer-fighting biological, which was developed at the University of Florida, has successfully reprogrammed the immune systems of four adult glioblastoma patients’ to attack the malignant brain tumors, according to results of the […]
AstraZeneca Admits Vaxzevria COVID Vaccine Can Cause Fatal Side Effects
AstraZeneca plc, the largest and most profitable pharmaceutical company in the United Kindgdom1 has admitted in court documents that its COVID-19 vaccine, Vaxzevria, which was developed in partnership with the University of Oxford, can cause the blood disorder thrombosis with thrombocytopenia syndrome (TTS) in “very rare cases.” TTS is an immune disorder specifically associated with […]
Pfizer Agrees to Settle Zantac Cancer Lawsuits for $250 Million
Pfizer, Inc., the largest pharmaceutical corporation in the world marketing drugs and vaccines,1 has agreed to pay between $200 to $250 million to settle more than 10,000 lawsuits filed in the United States related to cancer risks associated with its over-the-counter heartburn drug Zantac (also known as ranitidine). The acid reflux drug was discontinued in […]
Unknown Risks of COVID Shot Harm Revealed in New Report
At the request of the Health Resources Services Administration (HRSA), an agency in the U.S. Department of Health and Human Services (DHHS), the National Academies of Science, Engineering and Medicine assembled a committee of physicians and scientists to conduct a review of the evidence that COVID-19 shots can cause serious harm to health. The evidence […]
NC Court Rules Federal PREP Act Protects Forced Vaccination Without Parental Consent
A North Carolina Court of Appeals found that a clinic, where personnel gave a 14-year-old boy a COVID-19 shot without his consent or parental consent, was protected by the Public Readiness and Emergency Preparedness Act (PREP Act). The court concluded that the Guilford Board of Education, which hosted the clinic, was also covered by the […]
CDC Pushes Pfizer’s Pentavalent Meningococcal Vaccine
On Oct. 20, 2023, Pfizer, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its new pentavalent meningococcal vaccine, Penbraya, which targets five meningococcal serogroups (A, B, C, W and Y) that most commonly cause meningococcal disease in adolescents and young adults 10-25 years old. Penbraya, is recommended to be given in two […]